Quantitative Evaluation of the Real-World Harmonization Status of Laboratory Test Items Using External Quality Assessment Data
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: In recent decades, the analytical quality of clinical laboratory results has substantially increased because of collaborative efforts. To effectively utilize laboratory results in applications, such as machine learning through big data, understanding the level of harmonization for each test would be beneficial. We aimed to develop a quantitative harmonization index that reflects the harmonization status of real-world laboratory tests. Methods: We collected 2021–2022 external quality assessment (EQA) results for eight tests (HbA1c, creatinine, total cholesterol, HDL-cholesterol, triglyceride, alpha-fetoprotein [AFP], carcinoembryonic antigen [CEA], and prostate-specific antigen [PSA]). This EQA was conducted by the Korean Association of External Quality Assessment Service, using commutable materials. The total analytical error of each test was determined according to the bias% and CV% within peer groups. The values were divided by the total allowable error from biological variation (minimum, desirable, and optimal) to establish a real-world harmonization index (RWHI) at each level (minimum, desirable, and optimal). Good harmonization was arbitrarily defined as an RWHI value ≤ 1 for the three levels. Results: Total cholesterol, triglyceride, and CEA had an optimal RWHI of ≤ 1, indicating an optimal harmonization level. Tests with a desirable harmonization level included HDL-cholesterol, AFP, and PSA. Creatinine had a minimum harmonization level, and HbA1c did not reach the minimum harmonization level. Conclusions: We developed a quantitative RWHI using regional EQA data. This index may help reflect the actual harmonization level of laboratory tests in the field.
Abstract
Background: In recent decades, the analytical quality of clinical laboratory results has substantially increased because of collaborative efforts. To effectively utilize laboratory results in applications, such as machine learning through big data, understanding the level of harmonization for each test would be beneficial. We aimed to develop a quantitative harmonization index that reflects the harmonization status of real-world laboratory tests. Methods: We collected 2021–2022 external quality assessment (EQA) results for eight tests (HbA1c, creatinine, total cholesterol, HDL-cholesterol, triglyceride, alpha-fetoprotein [AFP], carcinoembryonic antigen [CEA], and prostate-specific antigen [PSA]). This EQA was conducted by the Korean Association of External Quality Assessment Service, using commutable materials. The total analytical error of each test was determined according to the bias% and CV% within peer groups. The values were divided by the total allowable error from biological variation (minimum, desirable, and optimal) to establish a real-world harmonization index (RWHI) at each level (minimum, desirable, and optimal). Good harmonization was arbitrarily defined as an RWHI value ≤ 1 for the three levels. Results: Total cholesterol, triglyceride, and CEA had an optimal RWHI of ≤ 1, indicating an optimal harmonization level. Tests with a desirable harmonization level included HDL-cholesterol, AFP, and PSA. Creatinine had a minimum harmonization level, and HbA1c did not reach the minimum harmonization level. Conclusions: We developed a quantitative RWHI using regional EQA data. This index may help reflect the actual harmonization level of laboratory tests in the field.
참고문헌 (19)
- Miller WG, "Harmonization and standardization : where are we now?", J Appl Lab Med, 6, pp.510~521 (2021)
- Plebani M, "Standardization and harmonization in laboratory medicine : not only for clinical chemistry measurands", Clin Chem Lab Med, 61, pp.185~187 (2023)
- Myers GL, "The International Consortium for Harmonization of Clinical Laboratory Results(ICHCLR)– a pathway for harmonization", EJIFCC, 27, pp.30~36 (2016)
- "The International Consortium for Harmonization of Clinical Laboratory Results" (2024)[URL]
- CLSI, "Preparation and validation of commutable frozen human serum pools as secondary reference materials for cholesterol measurement procedures", pp.52~ (1999), Clinical and Laboratory Standards Institute
- Cho EJ, "Commutability Assessment of Frozen Human Serum Pools for External Quality Assessment of Tumor Markers", Lab Med Qual Assur, 44, pp.111~120 (2022)
- Kim S, "Schemes and performance evaluation criteria of Korean Association of External Quality Assessment(KEQAS)for improving laboratory testing", Ann Lab Med, 41, pp.230~239 (2021)
- Oosterhuis WP, "The use of error and uncertainty methods in the medical laboratory", Clin Chem Lab Med, 56, pp.209~219 (2018)
- "The EFLM Biological Variation Database" (2024)[URL]
- Jones GRD, "Analytical performance specifications for EQA schemes –need for harmonization", Clin Chem Lab Med, 53, pp.919~924 (2015)
- Noorbakhsh-Sabet N, "Artificial intelligence transforms the future of health care", Am J Med, 132, pp.795~801 (2019)
- "Big data and AI: a comparative overview" (2024)[URL]
- Chen M, "Artificial intelligence in healthcare : an essential guide for health leaders", Healthc Manage Forum, 33, pp.10~18 (2020)
- Hallworth MJ, "The ‘70% claim’ : what is the evidence base?", Ann Clin Biochem, 48, pp.487~488 (2011)
- Kim HS, "Medical big data is not yet available : why we need realism rather than exaggeration", Endocrinol Metab(Seoul), 34, pp.349~354 (2019)
- Cho EJ, "A new strategy for evaluating the quality of laboratory results for big data research : using external quality assessment survey data(2010–2020)", Ann Lab Med, 43, pp.425~433 (2023)
- Kim S, "Laboratory data quality evaluation in the big data era", Ann Lab Med, 43, pp.399~400 (2023)
- "Laboratory Test Result Harmonization Status" (2024)[URL]
- Kim S, "Proposed model for evaluating real-world laboratory results for big data research", Ann Lab Med, 43, pp.104~107 (2023)